原发性脑横纹肌肉瘤导致颅外转移:非典型表现及诊断挑战的病例报告与叙述性综述
本文报告一例65岁男性原发性脑横纹肌肉瘤(PBRMS),表现为进行性右侧偏瘫,影像学见左额顶叶不均匀强化病灶,基线全身CT和PET未发现其他转移;行病灶根治性切除后经免疫组化(结蛋白和肌生成素阳性)确诊,立体定向放疗实现局部控制,但术后6个月出现右肺大转移灶需辅助化疗。文献综述显示预后差,44%患者诊断后1年内死亡,生存似与根治性切除、立体定向或必要时全中枢放疗耐受性及辅助化疗相关。
要点
- PBRMS术前影像学难以与其他恶性脑肿瘤区分,需组织学及免疫组化(结蛋白、肌生成素)确诊。
- 文献综述显示44%患者诊断后1年内死亡,预后差。
- 生存似与根治性切除、立体定向或必要时全中枢放疗及辅助化疗相关。
核心结论
- PBRMS术前影像学难以与其他恶性脑肿瘤区分,只有组织学可提示原发性或转移性横纹肌肉瘤,取决于是否存在其他远处病灶。
- 文献综述显示预后差:44%的患者在诊断后1年内死亡。
- 总体生存似乎与根治性切除、立体定向或必要时全中枢放疗的耐受性以及辅助化疗相关。
- 鉴于高复发率,密切监测和再分期至关重要。
研究设计与样本
- 病例报告并附叙述性文献综述。
主要发现
- 65岁男性,进行性右侧偏瘫3天,左额顶叶不均匀强化病灶;基线全身CT和PET未发现其他转移。
- 行病灶根治性切除,免疫组化结蛋白和肌生成素阳性确诊;立体定向放疗实现局部控制。
- 术后6个月出现右肺大转移灶,需辅助化疗。
- 文献综述显示44%的患者在诊断后1年内死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rhabdomyosarcoma is a rare malignant tumor originating from striated muscle cells. It accounts for only 3% of all soft tissue sarcomas in adults, and its metastases can also reach the central nervous system. Only sporadic cases of primary brain rhabdomyosarcoma (PBRMS) have been reported so far. CASE DESCRIPTION: We discuss the atypical presentation and diagnostic challenge of PBRMS in a 65-year-old man. He presented with a 3-day history of progressive right hemiparesis caused by an unspecific left frontoparietal heterogeneously enhancing lesion. Total body computed tomography and positron emission tomography scans performed at baseline did not reveal other secondarisms. The patient underwent radical excision of the lesion, which allowed to establish the diagnosis, with immunohistochemical staining positive for desmin and myogenin. Stereotactic radiotherapy guaranteed local disease control; nonetheless, the patient also required adjuvant chemotherapy when he developed large right lung metastases 6 months postoperatively. CONCLUSIONS: PBRMS can be hardly distinguished from other malignant brain tumors during preoperative radiologic workup; only histology can raise the suspicion of primary or metastatic rhabdomyosarcoma, depending on the presence of other distant lesions. Our review of the literature demonstrates that prognosis is poor: 44% of patients die within 1 year from diagnosis. Overall, survival seems to correlate with radical resection, tolerance of stereotactic or if necessary full neuraxis radiotherapy, and adjuvant chemotherapy. Given the high relapse rate, close monitoring and restaging are imperative.
引用
- Mallereau CH, Ganau M, Todeschi J, et al. Primary Brain Rhabdomyosarcoma Causing Extracranial Metastases: Case Report with Narrative Review of Atypical Presentations and Their Diagnostic Challenges. World Neurosurg. 2020. PMID: 32229305. doi:10.1016/j.wneu.2020.03.110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。